Genetic Differences in Propofol Pharmacodynamics in Children

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

March 11, 2020

Primary Completion Date

October 26, 2023

Study Completion Date

December 31, 2024

Conditions
Anesthesia
Interventions
DRUG

Propofol

At T0, a propofol infusion at a rate of 1.5 mg/kg/min will be started until apnea is achieved. Loss of consciousness will be defined clinically using loss of eyelash reflex (TLOER) and tolerance of nasal cannulae (TNC), tested every 10 sec., and by a BIS \<60 for 30 sec. (TBIS). Apnea will be defined as absence of end-tidal CO2 for at least 20 seconds (TAPNEA). A saliva sample with be taken under anesthesia for genome-wide association study and principal component analysis.

Trial Locations (1)

V6H 3V4

BC Children's Hospital - Department of Anesthesia, Vancouver

All Listed Sponsors
collaborator

BC Children's Hospital Research Institute

OTHER

lead

University of British Columbia

OTHER